# Pharmacokinetics of Ceftolozane/Tazobactam in Patients With Burns

> **NCT03002506** · PHASE4 · TERMINATED · sponsor: **Texas Tech University Health Sciences Center** · enrollment: 6 (actual)

## Conditions studied

- Burns
- Pharmacokinetics

## Interventions

- **DRUG:** Ceftolozane/tazobactam

## Key facts

- **NCT ID:** NCT03002506
- **Lead sponsor:** Texas Tech University Health Sciences Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-08-21
- **Primary completion:** 2020-06-01
- **Final completion:** 2020-06-30
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Much slower recruitment than anticipated
- **Last updated:** 2021-03-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03002506

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03002506, "Pharmacokinetics of Ceftolozane/Tazobactam in Patients With Burns". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03002506. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*